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Abstract 
Raman spectroscopy can identify cancerous from healthy tissue, with a chemical analysis from the 
measurement of vibrational bond frequencies. However, to detect small tumours a form of Raman 
imaging is required. Such imaging – by acquiring a Raman spectrum at each imaging pixel - can detect 
tumours, but is rather slow. Multi-photon versions of Raman – anti-Stokes Raman scattering (CARS) 
microscopy and stimulated Raman scattering (SRS) microscopy – offer similar accuracies in identifying 
cancerous tissue and tumor margins, but with a far higher speed which is beneficial for diagnosis of 
small tumors in tissue. SRS microscopy can also be used to image extrinsic molecules in living cells, 
such as anti-cancer drugs at typical concentrations. 
  
Introduction to Raman techniques 
Raman scattering of light by vibrational bonds in molecules and crystals (1) results in a photon losing 
a well-defined amount of energy in exciting the vibration. This is shown in the energy level diagram in 
Fig. 1. An alternative explanation is that measured frequency shifts of laser light after interacting with 
a sample, are equal to the frequencies of vibration of the bonds within that sample. Spectroscopy of 
the frequency-shifted light reveals many different vibrational modes present in a sample, and 
therefore is a measure of its chemistry. It is extremely well suited to characterizing living cells and 
tissues, as visible or near-infrared light can be focussed to produce very small focal volumes for 
intracellular measurement, and also high resolution images. It is minimally invasive at moderate laser 
powers, and does not require labels such as fluorophores or nanoparticles, so is appropriate for long 
term studies of living cells, and the diagnosis of disease in humans. 
However, for biological tissues the efficiency is low – only the order of 1 in 1010 photons is Raman-
shifted (2). This low efficiency is due to the excitation of a low frequency vibration with high frequency 
light. A good quality spectrum takes 1-100 secs to acquire, depending on laser wavelength and power. 
A Raman image can be produced by sequentially acquiring a Raman spectrum at each imaging pixel, 
but this is typically too slow for live cell imaging. Such a Raman spectrometer capable of confocal 
imaging (3) is depicted in Fig 2(a). By using a far higher power laser and distributing this power along 
a line at the sample by using a cylindrical lens, a line-scanning Raman system (4, 5) is able to acquire 
several spectra in parallel – from all the positions along the line focussed on the sample. This speeds 
us the Raman image acquisition time enough to enable live cell imaging. 
Coherent anti-Stokes Raman scattering (CARS) microscopy (6) uses two different laser frequencies to 
excite a molecular vibration much more efficiently. In order for 3 photons to interact in CARS, short 
laser pulses need to be applied. These pulse durations should ideally be matched to the vibrational 
lifetimes of molecular vibrations – typically 1 - 20 ps (7). Traditional ‘narrowband’ CARS uses 
picosecond lasers with well-defined frequencies, so that only one vibrational mode is excited within 
an image. This gives typically 5-6 orders of magnitude increase in signal levels (8) – hence imaging 
speeds can be as fast as video rate, but the downside is that only one vibrational mode is imaged. In 
order to provide more robust chemical imaging, more than one vibrational mode can be imaged 
sequentially by retuning one laser frequency between images, in what can be termed multi-spectral 
CARS (9). A schematic of a narrowband CARS microscope is shown in Fig 2(b). CARS also has the 
disadvantage of producing a signal which is proportional to the square of the concentration (hence 
low concentrations cannot be probed), and is combined with a constant background signal. These 
problems can be addressed in several ways (10-13), normally at the expense of imaging speed. 
Multiplex (or, hyperspectral) CARS (14) has one narrowband (picosecond) laser with sub-nanometer 
linewidth, and one broadband laser with tens or hundreds of nanometers linewidth, in order to excite 
a wide range of vibrational frequencies. This can either cover a relatively small range of the Raman 
spectrum, or the majority of the Raman spectrum of biomolecules. As the laser power of the 
broadband pulse is dispersed over a wide range of vibrational modes, and the resulting signal is split 
into a large number of channels on the CCD detector, it is significantly slower than narrowband CARS. 
It has the advantage of acquiring a spectrum or partial spectrum at each imaging pixel, rather than 
just the intensity of one peak within the spectrum. At down to 3.5ms per spectrum (15) - i.e. per pixel 
- its speed is comparable with line-scanning Raman systems. 
Stimulated Raman scattering (SRS) (16) offers speeds similar to narrowband CARS – as fast as video 
rate – with a linear dependence of the signal on concentration. In SRS two photons are absorbed more 
readily than single photons, so when the low energy (Stokes) beam is switched off, the amount of the 
high energy (pump) beam transmitted through the sample increases. Full modulation of the Stokes 
beam produces a modulation of <10-4 of the pump beam, which is measured with a lock-in amplifier 
(16). However, it cannot easily be extended to hyperspectral imaging. 
 
Raman spectroscopy of cancer tissues 
Raman spectroscopy was first applied to cancer tissue in 1996 (17), with principal component analysis 
(PCA) used for a quantitative assignment (as healthy or cancerous) in 1998 (18). Another statistical 
method, partial least squares was used to assign a chemical composition to cancerous tissue in 2005 
(19), from a known database of constituants. As spectroscopy is not the main thrust of this review, 
the reader is directed towards a review of Raman spectroscopy for cancer diagnosis (20). Most Raman 
spectroscopy cancer diagnosis is performed on ex vivo tissue, but has also been extended to blood 
serum (21). The combined use of Raman spectroscopy with metal nanoparticles, termed surface-
enhanced Raman spectroscopy (SERS) is reviewed here (22). 
Raman spectroscopy has been applied in vivo (23) with the use of an endoscopic probe (22). A review 
of in vivo Raman spectroscopy is presented here (24), and of in vivo cancer diagnosis here (25). 
An example set of Raman spectra are shown in Fig 3, from primary and secondary tumors in head and 
neck lymph nodes, and benign tissue for comparison (26). There is a high degree of similarity between 
spectra from all three types of tissue, which is to be expected given the relatively small differences 
between their biochemistries. In order to extract these small differences from the acquired spectra, 
and ignore the similarities, some statistical analysis is required. 
Each Raman spectrum can be decomposed into a set of basis spectra, with a measured spectrum 
processed into a linear composition of the basis set spectra. Several statistical methods exist, notable 
principal component analysis (PCA) (27), partial least squares (28), linear discriminant analysis (29), 
and ant colony analysis (30). For diagnosis of an unknown tissue (e.g. as healthy or cancerous), all 
techniques require a ‘training set’ of spectra from known tissue types (e.g. healthy and cancerous), 
and convert the complexity of a spectrum into the simplicity of a single data point normally in a two-
dimensional plot. An example is presented in Fig. 3, for spectra acquired on known primary tumors, 
secondary tumors, and benign tissue (26). Then, when an unknown sample is measured, its spectrum 
is inserted into the model and plotted with the training set – hence giving an assignment of what tissue 
type the spectrum most closely resembles. The accuracy of Raman measurements in cancer diagnosis 
is typically in the range 85-95%. Partial least squares analysis (31, 32) is also able to decompose spectra 
into a known spectral library of components (e.g. DNA, collagen, phospholipids). 
Although Raman spectroscopy offers a highly accurate measure of whether a small region of tissue is 
cancerous or not, by acquiring a single spectrum we cannot hope to find the extent of a tumor within 
healthy tissue. An averaged Raman spectrum over a large area of tissue would miss small tumors, as 
the spectrum would seem to be mostly healthy tissue. Spectroscopy cannot hope to identify tumor 
margins within tissue, so some type of imaging is required. Such a form of imaging based on Raman 
spectroscopy would be extremely useful in producing a label-free version of the current standard for 
tissue biopsy imaging – haematoxylin and eosin (H&E) staining, shown later in Fig 5b. 
 
Raman imaging of cancer tissues 
Confocal Raman imaging often uses spectral acquisition times of the order of 1 second at each imaging 
pixel to produce a hyperspectral image. Such a long pixel dwell time would be too slow for imaging of 
living cells, so to achieve sub-100 msec pixel dwell times a high power green laser is required (33). It 
has been reported that live cell confocal Raman imaging cannot be repeated for more than a handful 
of images, as cumulative photodamage occurs. Reducing the laser intensity by transforming focal spot 
into a line and acquiring line-scanning Raman images, would most likely not improve the acquisition 
rate because photodamage is cumulative and originates from photochemical reactions rather than 
any change in temperature. 
Some data analysis needs to be performed, as a spectrum cannot be displayed at each image pixel. 
Each Raman spectrum can be compared with a Raman spectra from other pixels within the image, to 
produce similar regions - this process is called cluster analysis (34) . Alternatively, spectra can be 
decomposed into a combination of spectra of suspected components from a library of spectra with 
partial least squares analysis, yielding quantitative images of the concentrations of these components. 
This was applied to a breast duct within healthy tissue, to produce images of the concentration of 
collagen, cell cytoplasm, and cell nucleus (35). In a similar way, the concentration of a drug within a 
cancer cell can be measured and imaged (36-38). 
Confocal Raman images have also been successfully classified into organelles within a cancer cell 
(nucleus, mitochondria, endoplasmic reticulum, Golgi apparatus, and cytoskeleton) (33). These 
images, displayed in Fig. 4, offer a label-free alternative to fluorescent dyes. 
The Lodz group (39-41) acquired confocal Raman images of cancerous and non-cancerous breast 
tissue, distinguishing them by their different biochemistries present in the Raman spectra. The best 
separation in images was given by the amount of carotenoids at 1518 cm-1, but also observed changes 
in protein and lipid content. 
Kong et al. (42) applied confocal Raman imaging to skin cancer, which is shown in Fig. 5. Converting 
the set of spectra into an image was achieved by k-means cluster analysis which separated images 
into regions which were assigned as basal cell carcinoma (BCC), muscle, fat, dermis, inflamed dermis, 
epidermis, substrate, and unknown. Comparison with stained tissue sections was good, but some 
areas identified as BCC were false positives. 
Although high resolution confocal Raman imaging has its uses in imaging cancer cells and tissue, its 
application to diagnosis of cancer tissue and cells is limited: a diffraction-limited spot is too small a 
sample volume to assign each pixel as cancerous or healthy. There is also a problem with scale: at 5-
20 hours per mm2 (42), it is far too slow for practical implementation as a replacement for 
haematoxylin & eosin staining. The Nottingham group (43) have used segmentation of 
autofluorescence or white light images of tissue to determine what are likely to be similar regions, 
then acquire one spectrum from each region. This is almost as effective as normal confocal Raman but 
speeds up image acquisition by a factor of ~100, so is applicable to samples of a few mm2. 
High speed Raman imaging of cancer tissues 
Confocal Raman imaging can be performed with a pixel dwell time of <50 msec using a high power 
laser, and line scanning Raman imaging with an acquisition time of 1 s per line (36). However, this 
acquisition time corresponds to several hours for an image with sufficient pixels required for cancer 
diagnosis of tissue. In order to improve potential throughput, CARS microscopy (either acquiring the 
intensity of one peak within the spectrum with narrowband CARS, or a full spectrum with multiplex 
CARS) has been applied to imaging of cancer cells and tissue. 
Narrowband CARS microscopy has been applied to cancer cells in a number of ways. Firstly, the 
technique is ideally suited to imaging of lipids, as lipids produce a strong signal at the C-H2 stretch 
frequency of 2845 cm-1, especially when concentrated into droplets in the cytoplasm. The Purdue 
group (44) demonstrated that lipid-rich environments promote metastasis, and were able to identify 
circulating tumor cells in vivo with CARS by their lipid content. 
Secondly, deuterated molecules can be introduced and tracked with narrowband CARS, as the stretch 
frequency of the C-D2 bond is shifted to 2150 cm-1. At this frequency there are no naturally occurring 
vibrational bonds in cells, so image contrast and detectability are highest. This was applied to 
measurement of lipid uptake in cancer cells (44), to monitor metabolism and kinetics. Although not 
strictly a label-free technique, deuterium substitution for hydrogen only has minor effects on the 
kinetics of molecules, whereas tagging with a fluorescent dye could dramatically affect the behaviour 
of molecules of interest – such as whether it is able to cross the cell membrane. 
Thirdly, by acquiring multiple images and rapidly retuning the frequency between each frame, a set of 
images can be acquired which have essentially the same information as hyperspectral imaging. Instead 
of acquiring a spectrum at each pixel position, a series of images at each vibrational frequency are 
acquired. This multi-spectral imaging has been applied to imaging of organelles in cancer cells (45), by 
acquiring images in the range 2800 - 3100 cm-1. Each pixel is assigned as either nucleus, nucleolus, 
endoplasmic reticulum, lipid droplet, Golgi apparatus, or mitochondria, by comparing the ‘spectrum’ 
of values using a supervised learning algorithm. Using this method, cellular imaging is free from the 
requirement of staining cells to reveal the presence of organelles. Results are similar to the acquisition 
of a full Raman spectrum at each pixel, which were shown in Fig. 4. 
SRS microscopy has been used on living cancer cells to also image organelles (46), by acquiring 80 
images in the frequency range 2840 – 3070 cm-1, with a total acquisition time of 3-4 minutes. 
Multivariate techniques were used to produce images of components (lipids, DMSO, and protein / 
nucleotide). 
SRS microscopy is well suited to imaging of external molecules, such as deuterated lipids and drugs, 
or amino acids (47). The SRS signal is linear in concentration, whereas CARS imaging produces signals 
which are quadratically dependent on concentration. Thus lower concentration limits can be probed 
with SRS. Molecules of interest can be ‘tagged’ with deuterium, or by modifying the molecule to 
contain a single alkyne bond which has a frequency of 2125 cm-1. Alkyne imaging (48) has reached a 
concentration level of 200 µM for a pixel dwell time of 100 µsec (49). This is demonstrated in Fig. 6, 
where an alkyne-tagged thymidine analog, 5-ethynyl-2′-deoxyuridine (EdU) is imaged in living cancer 
cells, where its presence is determined to be entirely within the nucleus. 
Narrowband CARS microscopy has been applied to cancer tissue. The Edinburgh group imaged 
paraffin-embedded breast cancer tissue sections, which were dewaxed to remove the paraffin – as 
well as other lipids. They acquired images (50) at a frequency of 1660 cm-1 (whose vibrations are 
dominated by proteins like those in Fig. 6), along with SHG of collagen. This label-free imaging showed 
a high degree of similarity with a haematoxylin & eosin stained section. Later the group refined this 
method to CARS imaging at 2930 cm-1 (51), which is the dominant Raman peak for proteins (52) and 
has been shown to be the dominant peak in Raman spectroscopy of cancerous tissue (53). When the 
group combined this CARS image with a TPEF image of autofluorescent elastin, and an SHG image of 
collagen, a 3-color label-free image in Fig. 7 is produced which displays significantly more information 
than the corresponding stained tissue. 
This multi-modal microscopy, comprising CARS, TPEF, and SHG, has also successfully been applied to 
skin cancer (54), but with a CARS frequency of 2850 cm-1 relating to the CH2 stretch. CARS can also be 
used to image cellular morphology. By tuning the frequency to 2845 cm-1, the cytoplasm is clearly 
visible as bright, with the nucleus appearing darker. Simply by comparing cell size and shape with 
known values for healthy and cancerous frozen lung tissue, an accuracy of diagnosis of over 90% was 
achieved (55). Brain tumors were identified by a reduction in the lipid content (56) with narrowband 
CARS imaging at the CH2 frequency (2850 cm-1). 
By combining CH2 and CH3 imaging at 2850 cm-1 and 2930 cm-1, brain tumors and tumor margins were 
clearly identified in SRS microscopy (57) with extremely good contrast and high specificity, over large 
areas. The technique was also applied in vivo, with the results shown in Fig. 8. Neuropathologists were 
used to give a correlation between SRS imaging and haematoxylin & eosin (H&E) staining, of κ = 0.98. 
 
Multiplex CARS (mCARS) microscopy could potentially offer superior contrast to narrowband CARS or 
SRS as it acquires a full or partial Raman spectrum at each pixel, albeit at the expense of imaging speed. 
In one publication, cancerous and non-cancerous cell lines are distinguished by mCARS imaging (58). 
When mCARS was applied to healthy brain tissue, spectra at each imaging pixel were classified as 
myelin, grey matter, granule cells and Purkinje cells using PCA (59), resulting in 4 separate images of 
these classifications. 
The most significant application of mCARS microscopy was in being able to differentiate cancer versus 
normal fresh tissue sections (53) with an accuracy above 99% and define cancer boundaries to +-100 
µm, again with an accuracy of more than 99%. Images of 63 x 63 pixels were acquired in less than 5 
minutes. The spectral differences were dominated by a higher CH2 peak at 2845 cm-1 for healthy tissue, 
and a higher CH3 peak at 2930 cm-1 for cancerous tissue, agreeing with the narrowband CARS results 
shown in Fig. 7. 
Conclusions 
Raman spectroscopy offers a high degree of accuracy when comparing healthy and cancerous tissue, 
so why do we need to perform Raman imaging? For pathology of tissue biopsies, sample sizes will be 
several millimetres or even centimeters in diameter. So tumors which are small relative to the size of 
the biopsy would be missed either by picking a spot at random, or by averaging the spectrum over a 
large area. Indeed, most Raman spectroscopy studies either use a large focal spot or average over a 
large area (0.1 – 1 mm in diameter) which is already clearly cancerous when viewed in the H&E stained 
image. 
Although confocal Raman microscopy may offer an improved accuracy over haematoxylin & eosin 
(H&E) staining, it would be a relatively slow replacement. Instead, a higher speed variant would be 
preferable – either line-scanning Raman microscopy or multiplex CARS offer reasonable imaging 
speeds of minutes per image, with the benefit of acquiring a full spectrum. However, it seems that for 
cancer diagnosis the main differences between healthy and cancerous tissue can be reduced to the 
CH3 and CH2 peaks within the spectrum. In this case, far higher speed can be achieved with 
narrowband CARS microscopy, or with SRS microscopy. When combined with SHG of collagen, and 
TPEF of elastin or cells, a multi-modal microscopy should enhance Raman-based chemical information 
with other signals which alter between healthy and cancerous tissue. This information could be either 
presented as a false color image to a pathologist, or combined into a quantitative value, of probability 
that the tissue is cancerous. One further benefit of high speed multi-modal imaging is that it can be 
acquired on fresh tissue, so 3D image stacks can be acquired. 
In vivo imaging is hard to achieve at imaging depths more than a few millimeters using optical 
techniques. For this reason, in vivo cancer imaging will be greatly limited in humans, to skin cancers 
or where endoscopy can be performed. Even so, there are significant technical issues with performing 
multi-photon endoscopy. 
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Figures 
 
Fig. 1. Energy level diagram for Raman scattering, coherent anti-Stokes Raman scattering (CARS), 
stimulated Raman scattering (SRS), second harmonic generation (SHG), and two-photon excitation 
fluorescence (TPEF). The letter ‘m’ refers to the photon which is measured, all other photons being 
required for illumination. 
  
  
Fig. 2. (a) Schematic of a confocal Raman spectrometer. In the first case, without a cylindrical lens 
present the Raman spectrum is acquired from the region of a diffraction-limited spot in the sample. 
This system acts as a confocal Raman microscope when the sample stage is raster-scanned and a 
spectrum acquired from each position. With a cylindrical lens present, a line-scanning Raman 
microscope is created. For line-scanning, effectively many separate focal spots are created along a line 
across the sample, with all the corresponding spectra recorded in parallel on the CCD detector. (b) 
Multi-photon microscope used for high speed Raman imaging – coherent anti-Stokes Raman scattering 
(CARS) microscopy and stimulated Raman scattering (SRS) microscopy, and complementary imaging 
techniques of two-photon excitation fluorescence (TPEF) and second harmonic generation (SHG). The 
laser produces picosecond pulses of one wavelength (in this case 1064 nm), and an optical parametric 
oscillator (OPO) provides a tuneable wavelength (700 - 1000 nm). These beams are combined so that 
after passing through the objective lens (obj), they are both focussed at the same position on the 
sample, and are raster-scanned to produce an image. The frequency difference between the laser and 
OPO is chosen to match a vibrational frequency of interest. For modularity, signals are collected by 
multimode fibres and relayed to the detectors. In CARS, TPEF and SHG, high speed photomultiplier tube 
(PMT) detectors are used to acquire signals. In SRS microscopy, an acousto-optic modulator (AOM) 
‘chops’ the intensity of laser light, and a lock-in amplifier records the modulation of the transmitted 
OPO light measured by a silicon photodiode. 
  
 Fig. 3. (Top:) Mean Raman spectra for each group of lymph nodes from the head and neck. Regions 
within frozen sections of lymph node tissue were assigned as primary tumor, secondary tumor, or 
healthy, by 3 pathologists investigating H&E stained sections. The shaded regions indicate +/- 1 
standard deviation from the mean. (Bottom:) Linear discriminant analysis (LDA) plots for the three 
groups, using significant components from principal component analysis (PCA). Components which 
showed a significant difference between the pathology groups at a 99% confidence level were used as 
the inputs to LDA (26). 
  
 Fig. 4. Comparison of fluorescently labelled cells (a–d) and label-free Raman microscopy (e–h) of 
organelles. Actin is highlighted in red in (a) and (e), Golgi apparatus is in green in (b) and (f), the nucleus 
is in blue in (c) and (g), and images are merged into (d) for fluorescence labelling, and (h) for label-free 
Raman microscopy (33). 
  
 Fig. 5. Diagnosis of basal cell carcinoma (BCC) by Raman microspectroscopy (RMS). Tissue sections: (A 
and B) nodular BCC; (C) BCC-negative skin sample containing hair follicles with morphology similar to 
that of BCC (black arrows). Unsectioned tissue layers: (D) infiltrative BCC; (E) superficial BCC. The 
histopathology images for adjacent sections are included for comparison. (Scale bars: 400 μm.) False 
positives are indicated by red arrows in (A). (42) 
  
 Fig. 6. Live SRS imaging of HeLa (cervical cancer) cells, incubated with 100 μM 5-ethynyl-2′-
deoxyuridine (EdU), at three different frequencies. (Left:) The alkyne stretch frequency 2125 cm-1, 
(centre:) a control image acquired at a frequency 2000 cm-1 – well away from the alkyne vibration, 
(right:) amide frequency 1655 cm-1 dominated by proteins. Together these images show that (i) alkyne-
containing EdU is present only in the nucleus, and (ii) images have a very low background when not 
tuned to a particular vibrational bond. Scale bars, 10 μm (48). 
  
 Fig. 7. (Left:) Haematoxylin & eosin (H&E) stain of paraffin-embedded breast ductal carcinoma tissue 
section. Lipids and paraffin were removed by dewaxing in xylene. (Centre:) label-free multimodal 
image of an adjacent tissue section. CARS image obtained at the CH3 vibration wavenumber 
(2930 cm−1) in proteins (red) highlighting the solid tumors lying in a connective tissue composed of 
fibrous collagen and elastin probed with SHG (blue) and TPEF (green), respectively. The image 
acquisition time was 21 s per image, and image sizes are 100 × 75 µm. (Right:) transmitted light image 
of unstained tissue, of an adjacent section. 
  
 Fig. 8. In vivo SRS microscopy images of human glioblastoma multiforme (GBM) xenografts. SRS 
imaging was carried out via acute cranial window preparation in mice 24 days after implantation of 
human GBM xenografts. (A) Bright-field microscopy appears grossly normal, whereas SRS microscopy 
within the same region demonstrates distinctions between tumor-infiltrated areas and non-infiltrated 
brain (normal), with a normal brain–tumor interface (dashed line). (B to D) High magnification views 
within the tumor (B), at the tumor-brain interface (C), and within normal brain (D). (57) 
 
